Early stage treatment discussion

[Jean]

Valerie,
I understand - the history of herceptin was so profound when given to the advanced stage patients that it could not be ignored. In most studies with new drugs and treatments that are being researched are usually with the later stage patients and in this area the early stage patients benefit. In this area Herceptin was fast tracked. The trials showed herceptin effectiveness in the clinical trials.

There is a new trial with bc patients who are older and may have other health issues where chemo may not be the best choice for them - that study will be a strong additive to us in the future.

For the present time we are faced with an aggressive form of bc - that is showing via studies that we are gaining on this disease with those treatments. There is no free lunch with this disease. We are changing the odds. In the coming years hopefully we will have the answers that may allow yet another change in treatment.

While not everyone will experience a recurrence (thank the good Lord) we do not have the ability to know who will and who will not.

I like Becky would do what we know works with Her2 pathology...as from your post so would you.

Jean